scabies
SCABIES
Scabies is a contagious disease caused by the mite Sarcoptes scabiei var hominis.
The affected individual usually complains of having a highly pruritic rash that occurs at night.
It occurs more often in children <15 years of age, sexually active young adults, the immunocompromised and in persons living in crowded living conditions (eg nursing homes, military barracks).
Transmission is typically by direct skin contact with an infected person and in adults, sexual transmission is common.

Introduction

  • Diagnosis is made based on clinical presentation & can be confirmed by microscopic identification of mites, eggs or mite feces
  • Scabies should be suspected in a patient who presents w/ a highly pruritic rash w/ nocturnal predominance
    • Scabies is highly suggested if there is also a history of contact w/ an infected person or if there is a history of contact w/ family member or sexual partner who has pruritic lesions w/ nocturnal predominance
  • Scabies is caused by the mite: Sarcoptes scabiei var hominis

Signs and Symptoms

Clinical Presentation

  • Occurs more often in children <15 yr, sexually active young adults, the immunocompromised & in persons living in crowded living conditions (eg nursing homes, military barracks)
  • Transmission is typically by direct skin contact w/ an infected person & in adults, sexual transmission is common
    • Though there is limited documentation, transmission by fomites may be possible (esp in cases of crusted scabies where a large amt of parasites are involved)
    • The mites can live for up to 30 days on a host & remain alive for 3 days on furniture, bedding etc
Signs & Symptoms
  • Primary symptom is generalized pruritus, which is usually worse at night
    • Pruritus is caused by a hypersensitivity reaction to the mite & its products (saliva, eggs & feces) once the host becomes sensitized
    • Hypersensitivity occurs 4-6 wk after infestation but occurs in 1-4 days w/ re-infestation because the host has been previously sensitized
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 05 Dec 2017

Results of a study conducted by the Chinese University of Hong Kong (CUHK) revealed that patients who recovered from hepatitis B virus (HBV) infection are still at risk for hepatocellular carcinoma (HCC). 

30 Mar 2018
A US study suggests that expanding HIV screening to reduce undiagnosed infections and increasing access to care and treatment to achieve viral suppression are important to lessen HIV transmission. It is also imperative that prevention methods, such as condoms and pre-exposure prophylaxis, be easily accessed, particularly among young men who have sex with men (MSM) and MSM of colour.
Saras Ramiya, 5 days ago
The National Institutes of Health (NIH) and International Medical University (IMU) strengthens their research collaboration with the recent signing of a Memorandum of Understanding (MoU).
27 Jan 2018
In patients with chronic hepatitis B virus (HBV) infection, tenofovir alafenamide (TAF) shows comparable 96-week efficacy and improved renal and bone safety with tenofovir disoproxil fumarate (TDF), a recent study has shown.